Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-018-1797-9
Abstract: Coagulation Factor XI (FXI) contributes to the pathobiology of sepsis-associated thrombosis and is a target for new therapeutics. Through cleavage of disulfide bonds, FXI becomes reduced (rFXI), accelerating intrinsic coagulation cascade activation. The role of…
read more here.
Keywords:
sepsis;
coagulation;
rfxi;
septic patients ... See more keywords